Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in Situ|Male Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: omega-3 fatty acid|OTHER: placebo|OTHER: laboratory biomarker analysis
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)